Psychiatry - OPEN Foundation

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression

O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019

Hallucinogens and Their Therapeutic Use: A Literature Review

BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019

Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.

Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019

MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.

Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019

Classical psychedelics for the treatment of depression and anxiety: A systematic review.

Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019

Esketamine for treatment resistant depression.

Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., ... & Demas, M. L. | Expert Review of Neurotherapeutics | 16 July 2019

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019

Psychedelic microdosing benefits and challenges: an empirical codebook.

Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., ... & Hapke, E. | 10 July 2019 | Harm reduction journal

Harnessing Neuroimaging to Enhance Our Understanding of the Effects of Ketamine in Depression.

Jaworska, N., & Phillips, J. L. | Cognitive neuroscience and neuroimaging | 1 July 2019

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019

Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Hashimoto, K. | Psychiatry and Clinical Neurosciences | 19 June 2019

Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants.

Derntl, B., Hornung, J., Sen, Z. D., Colic, L., Li, M., & Walter, M. | Frontiers in neuroscience | 18 June 2019

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial.

Almeida, R. N., Galvão, A. C. D. M., Da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., ... & Galvão-Coelho, N. | Frontiers in psychology | 4 June 2019

Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers

Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019

Psychedelic-assisted therapies: The past, and the need to move forward responsibly.

Gardner, J., Carter, A., O’Brien, K., & Seear, K. | International Journal of Drug Policy | 25 May 2019

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin

Lord, L. D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K., Lambiotte, R., & Cabral, J. | NeuroImage | 25 May 2019

Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.

Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K. | Acta neuropsychiatrica | 20 May 2019

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 14 May 2019

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., ... & Doblin, R. | Psychopharmacology | 7 May 2019